A cell-permeable, metabolically-stable analog of cAMP that acts as a competitive inhibitor of protein kinase A. Lipophilic analog of the cAMP antagonist Rp-cAMPS (Cat. No.
116814). Preferentially inhibits type I PKA (IC
50 = ~50 µM).
Note: 5 µmol = 2 mg.
|
Product information
|
|
Form
|
Lyophilized
|
|
Primary Target
|
PKA 1
|
|
Primary Target IC50
|
50 µM
|
|
Secondary target
|
Cholera toxin (IC50=300 µM)
|
|
Molar mass
|
401.7
|
|
Hygrocopic
|
Yes
|
|
Cell permeable
|
Yes
|
|
ATP Competitive
|
Yes
|
|
Purity
|
≥98% by HPLC
|
|
Solubility
|
H2O
|
|
Chemical formula
|
C10H10ClN5O5PS · Na
|
|
CAS number
|
142754-27-6
|
|
Declaration
|
Sold under license of Patent DE 3,802,865.4 issued to BIOLOG LSI.
|
|
Store and ship information
|
|
|
|
Storage
|
-20°C
|
|
Ship
|
Ambient Temperature Only
Standard Handling
|